$CSBR
CHAMPIONS ONCOLOGY, INC. Stock $csbr

$csbr Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000162828019003086 Filed on March 18, 2019

Income Statement

Concept	2019 Q1	2018 Q2	2018 Q1
Revenue	$6.430M	$4.920M	$5.082M
YoY Change	26.52%	32.26%	42.55%
Cost Of Revenue	$3.429M	$2.820M	$2.473M
YoY Change	38.66%	9.73%	2.61%
Gross Profit	$3.001M	$2.110M	$2.609M
YoY Change	15.02%	83.48%	124.91%
Gross Profit Margin	46.67%	42.89%	51.34%
Selling, General & Admin	$2.102M	$1.610M	$1.631M
YoY Change	28.88%	-34.55%	4.42%
% of Gross Profit	70.04%	76.3%	62.51%
Research & Development	$1.269M	$1.090M	$1.045M
YoY Change	21.44%	0.93%	4.71%
% of Gross Profit	42.29%	51.66%	40.05%
Depreciation & Amortization	$127.0K	$110.0K	$98.00K
YoY Change	29.59%	175.0%	188.24%
% of Gross Profit	4.23%	5.21%	3.76%
Operating Expenses	$6.800M	$2.700M	$5.149M
YoY Change	32.06%	-23.73%	3.69%
Operating Profit	-$370.0K	-$590.0K	-$67.00K
YoY Change	452.24%	-75.31%	-95.22%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$1.000K	-$20.00K	-$7.000K
YoY Change	-114.29%	0.0%	-12.5%
Pretax Income	-$369.0K	-$620.0K	-$74.00K
YoY Change	398.65%	-74.27%	-94.75%
Income Tax	$0.00	$20.00K	$2.000K
% Of Pretax Income
Net Earnings	-$369.0K	-$630.0K	-$76.00K
YoY Change	385.53%	-73.97%	-94.61%
Net Earnings / Revenue	-5.74%	-12.8%	-1.5%
Basic Earnings Per Share	-$0.03		-$0.01
Diluted Earnings Per Share	-$0.03	-$57.27K	-$0.01
COMMON SHARES
Basic Shares Outstanding	11.51M shares		10.99M shares
Diluted Shares Outstanding	11.51M shares		10.99M shares

Balance Sheet

Concept	2019 Q1	2018 Q2	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.310M	$860.0K	$1.060M
YoY Change	212.26%	-73.94%	-69.63%
Cash & Equivalents	$3.310M	$856.0K	$1.100M
Short-Term Investments
Other Short-Term Assets	$300.0K	$290.0K	$190.0K
YoY Change	57.89%	-3.33%	-64.81%
Inventory
Prepaid Expenses
Receivables	$3.919M	$3.917M	$2.942M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.527M	$5.060M	$4.189M
YoY Change	79.68%	-13.78%	-30.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.578M	$2.083M	$1.980M
YoY Change	30.2%	71.3%	194.64%
Goodwill	$669.0K	$669.0K	$669.0K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$137.0K	$116.0K	$107.0K
YoY Change	28.04%	8.41%	-28.67%
Total Long-Term Assets	$3.384M	$3.018M	$2.906M
YoY Change	16.45%	40.9%	94.9%
TOTAL ASSETS
Total Short-Term Assets	$7.527M	$5.060M	$4.189M
Total Long-Term Assets	$3.384M	$3.018M	$2.906M
Total Assets	$10.91M	$8.078M	$7.095M
YoY Change	53.78%	0.84%	-5.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.116M	$2.154M	$1.961M
YoY Change	7.9%	16.31%	48.11%
Accrued Expenses	$641.0K	$569.0K	$365.0K
YoY Change	75.62%	-16.93%	11.62%
Deferred Revenue	$4.723M	$4.704M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$220.0K	$30.00K	$30.00K
YoY Change	633.33%
Total Short-Term Liabilities	$7.704M	$7.453M	$6.177M
YoY Change	24.72%	0.08%	17.17%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$20.00K	$20.00K
YoY Change	-100.0%
Other Long-Term Liabilities	$151.0K	$151.0K	$446.0K
YoY Change	-66.14%	-7.93%	90.6%
Total Long-Term Liabilities	$151.0K	$151.0K	$446.0K
YoY Change	-66.14%	-7.93%	90.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.704M	$7.453M	$6.177M
Total Long-Term Liabilities	$151.0K	$151.0K	$446.0K
Total Liabilities	$8.588M	$8.075M	$6.623M
YoY Change	29.67%	6.1%	20.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$70.40M	-$70.83M	-$70.19M
YoY Change	0.29%	2.13%	4.88%
Common Stock	$72.77M	$72.08M	$71.92M
YoY Change	1.18%	1.52%	2.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00	$1.252M	$1.252M
YoY Change	-100.0%	0.0%	0.0%
Treasury Stock Shares	0.000 shares	269.7K shares	269.7K shares
Shareholders Equity	$2.323M	$3.000K	$472.0K
YoY Change
Total Liabilities & Shareholders Equity	$10.91M	$8.078M	$7.095M
YoY Change	53.78%	0.84%	-5.98%

Cashflow Statement

Concept	2019 Q1	2018 Q2	2018 Q1
OPERATING ACTIVITIES
Net Income	-$369.0K	-$630.0K	-$76.00K
YoY Change	385.53%	-73.97%	-94.61%
Depreciation, Depletion And Amortization	$127.0K	$110.0K	$98.00K
YoY Change	29.59%	175.0%	188.24%
Cash From Operating Activities	$1.210M	$10.00K	$440.0K
YoY Change	175.0%	-97.5%	-164.33%
INVESTING ACTIVITIES
Capital Expenditures	-$200.0K	-$210.0K	-$80.00K
YoY Change	150.0%	-64.41%	-46.67%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$200.0K	-$210.0K	-$80.00K
YoY Change	150.0%	-64.41%	-46.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	350.0K	-10.00K	30.00K
YoY Change	1066.67%		-400.0%
NET CHANGE
Cash From Operating Activities	1.210M	10.00K	440.0K
Cash From Investing Activities	-200.0K	-210.0K	-80.00K
Cash From Financing Activities	350.0K	-10.00K	30.00K
Net Change In Cash	1.360M	-210.0K	390.0K
YoY Change	248.72%	10.53%	-157.02%
FREE CASH FLOW
Cash From Operating Activities	$1.210M	$10.00K	$440.0K
Capital Expenditures	-$200.0K	-$210.0K	-$80.00K
Free Cash Flow	$1.410M	$220.0K	$520.0K
YoY Change	171.15%	-77.78%	-197.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q2	csbr	Assetsin Progress Gross AssetsinProgressGross	15000	USD
CY2019Q1	csbr	Assetsin Progress Gross AssetsinProgressGross	25000	USD
CY2019Q1	csbr	Capital Lease Obligations Noncurrent Excluding Interest CapitalLeaseObligationsNoncurrentExcludingInterest	0	USD
CY2014Q4	csbr	Monthly Capital Lease Payment MonthlyCapitalLeasePayment	3000	USD
CY2018Q3	csbr	Monthly Capital Lease Payment MonthlyCapitalLeasePayment	11000	USD
	csbr	Numberof Operating Subsidiaries NumberofOperatingSubsidiaries	2	subsidiary
	csbr	Reversalof Provisionfor Doubtful Accounts ReversalofProvisionforDoubtfulAccounts	0	USD
	csbr	Reversalof Provisionfor Doubtful Accounts ReversalofProvisionforDoubtfulAccounts	53000	USD
	csbr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Aggregate Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAggregateIntrinsicValueGranted	0	USD
	csbr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Grant In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantInPeriodWeightedAverageRemainingContractualTerm	P5Y6M25D
	csbr	Share Based Compensation Arrangement By Share Based Payment Award Options Canceled In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod	40183	shares
	csbr	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P8Y1M18D
CY2018Q2	csbr	Share Based Compensation Arrangement By Share Based Payment Award Warrants Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstanding	2004284	shares
CY2019Q1	csbr	Share Based Compensation Arrangement By Share Based Payment Award Warrants Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstanding	1671440	shares
	csbr	Share Based Compensation Arrangements By Share Based Payment Award Options Canceled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice	2.10
	csbr	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Canceled SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueCanceled	628128	USD
	csbr	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercised SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised	668195	USD
	csbr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises In Period Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRemainingContractualTerm	P4Y8M18D
CY2019Q1	csbr	Working Capital Deficit WorkingCapitalDeficit	-177000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--04-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-01-31
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000771856
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11615272	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	CHAMPIONS ONCOLOGY, INC.
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Trading Symbol TradingSymbol	CSBR
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2154000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2116000	USD
CY2018Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	1827000	USD
CY2019Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2367000	USD
CY2018Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3930000	USD
CY2019Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3932000	USD
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3917000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3919000	USD
CY2018Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	569000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	641000	USD
CY2018Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1468000	USD
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1901000	USD
CY2018Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	72070000	USD
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	72756000	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	75000	USD
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	88000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	335000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	152000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	848000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	335000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	498000	USD
CY2018Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4523129	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4161608	shares
CY2018Q2	us-gaap	Assets Assets	8078000	USD
CY2019Q1	us-gaap	Assets Assets	10911000	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	5060000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	7527000	USD
CY2018Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	26000	USD
CY2019Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	224000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	235000	USD
CY2018Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	17000	USD
CY2019Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	0	USD
CY2018Q2	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	130000	USD
CY2019Q1	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	366000	USD
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	234000	USD
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	224000	USD
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-320000	USD
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	16000	USD
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	10000	USD
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	224000	USD
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	218000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	72000	USD
CY2018Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	973000	USD
CY2019Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1086000	USD
CY2018Q2	us-gaap	Cash Cash	856000	USD
CY2019Q1	us-gaap	Cash Cash	3310000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3310000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3295000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1062000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1006000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3310000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2233000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2304000	USD
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11277675	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11612700	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11003228	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11612700	shares
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	11000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2018Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4704000	USD
CY2019Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4723000	USD
CY2018Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4704000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4723000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2473000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7737000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3429000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9963000	USD
CY2018Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	454000	USD
CY2019Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	733000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	98000	USD
	us-gaap	Depreciation Depreciation	233000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	127000	USD
	us-gaap	Depreciation Depreciation	353000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	253000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	433000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	970000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y3M
CY2018Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	73000	USD
CY2019Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	127000	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1004000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3167000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1223000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3311000	USD
CY2018Q2	us-gaap	Goodwill Goodwill	669000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	669000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-74000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-826000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-369000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	381000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	124000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-46000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	669000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	55000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1059000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	19000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	21000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-115000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	11000	USD
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	-302000	USD
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	-279000	USD
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2651749	shares
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	15000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	8000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	480000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	583000	USD
CY2018Q2	us-gaap	Liabilities Liabilities	8075000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	8588000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8078000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10911000	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7453000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	7704000	USD
CY2017Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1500000.0	USD
CY2018Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2490000	USD
CY2019Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3241000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1387000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1017000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-693000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1235000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1610000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-76000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-844000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-844000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	483000	USD
	us-gaap	Net Income Loss NetIncomeLoss	381000	USD
	us-gaap	Net Income Loss NetIncomeLoss	381000	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-76000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-844000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-369000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	381000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-71000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	267000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-369000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	5149000	USD
	us-gaap	Operating Expenses OperatingExpenses	16074000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	6800000	USD
	us-gaap	Operating Expenses OperatingExpenses	18962000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-67000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-755000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-370000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	386000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	8859000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1102000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1139000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1161000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1077000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	4225000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	155000	USD
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	116000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	137000	USD
CY2018Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	151000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	151000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-71000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1017000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	693000	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	287000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	298000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	38000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1440000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3551000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4479000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2083000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2578000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	19000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3308000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	53000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1045000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1269000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3550000	USD
CY2018Q2	us-gaap	Restricted Cash RestrictedCash	150000	USD
CY2019Q1	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2018Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	150000	USD
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-70826000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-70445000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-70400000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5082000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15319000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6430000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	19348000	USD
CY2018Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	627000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1862000	USD
CY2019Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	879000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2138000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	848000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	498000	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.856
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0198
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2135088	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.89
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2782000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	16667	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	370626
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	8375	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	206790	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.32
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.95
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.76
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.03
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5265000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	22036000	USD
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2705845	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2490168	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.85
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.45
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	22036000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2490168	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.45
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	57000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.18
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.86
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	20087000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y1M24D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M25D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y6M25D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	357242	shares
CY2018Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1034000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	365000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	3000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	603000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	1992000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	2323000	USD
CY2018Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	269685	shares
CY2019Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2018Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1252000	USD
CY2019Q1	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2018Q2	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	2103000	USD
CY2019Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	1565000	USD
CY2018Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	151000	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	151000	USD
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10994434	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10987797	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11508180	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13909063	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10994434	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10987797	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11508180	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11257314	shares

Files In Submission

Name	View Source	Status
0001628280-19-003086-index-headers.html	Edgar Link	pending
0001628280-19-003086-index.html	Edgar Link	pending
0001628280-19-003086.txt	Edgar Link	pending
0001628280-19-003086-xbrl.zip	Edgar Link	pending
csbr-20190131.xml	Edgar Link	completed
csbr-20190131.xsd	Edgar Link	pending
csbr-20190131_cal.xml	Edgar Link	unprocessable
csbr-20190131_def.xml	Edgar Link	unprocessable
csbr-20190131_lab.xml	Edgar Link	unprocessable
csbr-20190131_pre.xml	Edgar Link	unprocessable
csbr10-q1312019.htm	Edgar Link	pending
csbrq3131201910-qex311.htm	Edgar Link	pending
csbrq3131201910-qex312.htm	Edgar Link	pending
csbrq3131201910-qex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CSBR
CHAMPIONS ONCOLOGY, INC. Stock $csbr

2019 Q1 Form 10-Q Financial Statement

#000162828019003086 Filed on March 18, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSBR CHAMPIONS ONCOLOGY, INC. Stock $csbr

2019 Q1 Form 10-Q Financial Statement

#000162828019003086 Filed on March 18, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSBR
CHAMPIONS ONCOLOGY, INC. Stock $csbr